amaxa eNews #4

Welcome to amaxa eNews #4!

This issue provides you with an update on the most recent developments in Nucleofector Technology supporting neuroscience research. Enjoy reading!

And if you like amaxa eNews please recommend it to your friends and colleagues.

Your amaxa team

Hot Topic: High-efficiency Transfection Offers New Possibilities in Neuroscience Research

High-efficiency transfection is a crucial prerequisite to performing applications such as RNAi-mediated gene silencing in primary neurons. Traditional non-viral transfection methods are often ineffective, toxic, or both when applied to post-mitotic cells such as primary neurons. Nucleofection overcomes these limitations and enables many biomolecular applications for primary neurons...

Read more

Product Information

Whether you are performing biomolecular analyses such as quantitative PCR or western blot studies, or analyzing your samples via microscopy, Nucleofector Technology is the ideal tool to advance your neuroscience research.

amaxa’s latest products facilitate high-efficiency nucleofection of primary neurons using very small cell numbers, in single cuvette or in microplate format.

Read more

Application Note

Down-regulation of Staufen2, a key component of the RNA localization mechanism, in hippocampal neurons.

Localization of mRNAs is an efficient way to target gene products to specific regions in a cell. In mammals, RNA localization…

Read more

Webinar

amaxa's online user webinar on 'Nucleofection of Primary Neurons' was a great success. Watch a complete replay and get important tips and latest news from our R&D and Scientific Support Teams on e.g.:

	Neuron Isolation and Cell Handling
	Important Points for Nucleofection
	Post-Nucleofection Culture

View Webinar

Related FAQs

Our frequently asked questions list contains useful tips and hints as well as background information on the nucleofection of primary neurons.

View List

Related Citations

Around 200 citations attest to our Nucleofector Technology being a valuable tool to accelerate your neurobiology research.

View List to see a selection of them.
To see all citations visit our Citations Database and select the Research Area 'Neurobiology'.

View List

New Small Cell Number Nucleofector Kit

amaxa's new Basic Neuron Small Cell Number (SCN) Nucleofector Kit allows transfection of extremely low cell numbers with excellent efficiencies and viabilities.

Download SCN Kit Flyer

Video

Customers show how they use Nucleofector Technology for efficient transfection of Human Neural Stem Cells.

See customer video

Meetings & Shows

amaxa's Meeting Calendar from December 2007 to May 2008.

amaxa's Website

Next Issue

amaxa eNews #5
coming in March 2008

Hot Topic: Cancer Research

Next Online User Webinar

Attend amaxa's next online user webinar on

'Cell Line Optimization and Basic Nucleofector Kits'

register here

Subscribe

Subscribe here to receive future issues of amaxa eNews.

Invite a friend

Recommend amaxa's eNews to a friend or colleague.

You have received this e-mail because you have subscribed to amaxa eNews.
If you do no longer wish to receive amaxa eNews please unsubscribe here or log into your amaxa account to manage your subscriptions.

The Nucleofector Technology, comprising Nucleofection Process, Nucleofector Device, Nucleofector Solutions, Nucleofector 96-well Shuttle System and Nucleocuvette plates and modules is covered by patent and/or patent pending rights owned by amaxa AG.

amaxa, Nucleofector, nucleofection, maxGFP, 96-well Shuttle and Nucleocuvette are either registered trademarks or trademarks of amaxa AG in the U.S. and/or Germany and/or other countries. Other product and company names mentioned herein are the trademarks of their respective owners.

amaxa disclaims all warranties, whether expressed or implied, including any warranty as to the quality, accuracy, safety, or suitability of the information provided in this e-newsletter for any particular purpose. Any use of the information contained on any page of this e-newsletter is evidence of agreement with these terms of use.